Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor

已完结 20 由小小发布于 2026/7/30 15:19:12

DOI: 10.1021/acsmedchemlett.2c00502
文献类型：期刊论文
补充材料：仅需补充材料
文献链接：https://doi.org/10.1021/acsmedchemlett.2c00502

American Chemical Society (ACS)

Abstract：B cell lymphoma 6 (BCL6), a highly regulated transcriptional repressor, is deregulated in several forms of non-Hodgkin lymphoma (NHL), most notably in diffuse large B-cell lymphoma (DLBCL).

应助信息

1天前

打酱油

75ba00358be711f1b13434735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/7/30 15:19:12 未找到该文献，机器人已退出，请等待人工下载

2026/7/30 15:19:12 Book学术AI机器人收到请求，开始寻找文献

2026/7/30 15:19:12 已向机器人发送请求

1天前

小小发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierFunctional impairment in patients undergoing major orthopaedic surgery under general anaesthesia with or without regional anaesthesia: a target trial emulation using a national hospital claims database.